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CMR for Mapping the Missing Dimension in Ventricular
Tachycardia Ablation*
Saman Nazarian, MD
Baltimore, MarylandVentricular arrhythmias include triggered, auto-
matic, and re-entrant rhythms that involve the
ventricular muscle, the conduction system distal to
the His bundle, or a combination of both tissues.
Ventricular arrhythmias most commonly occur in
the setting of myocardial scar, but can also occur
See page 278
without observable structural abnormalities. Non-
sustained ventricular arrhythmia can be symptom-
atic and may lead to time-dependent left ventricular
dysfunction. If sustained, ventricular arrhythmia
can result in hemodynamic collapse with syncope or
sudden death.
Implantable cardioverter defibrillators (ICDs) of-
fer excellent protection from sudden death due to
ventricular arrhythmia. However, adjunctive thera-
pies are often necessary to reduce shocks in ICD
recipients. Catheter ablation is a viable option for
ventricular tachycardia (VT) suppression when an-
tiarrhythmic medications fail, or as primary therapy
(1). However, despite significant advances in tech-
niques for VT ablation, success rates remain lim-
ited. Enhanced methodologies to assess the VT
substrate and the effect of ablation upon that
substrate will likely improve outcomes. In this issue
of iJACC, Ilg et al. (2) report the use of cardiac
magnetic resonance (CMR) for assessment of struc-
tural modifications after ablation of idiopathic pre-
mature ventricular contractions and VT.
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Division of Cardiology/Cardiac Arrhythmia, Johns Hopkins
University, Baltimore, Maryland.The Missing Dimension of Surface Mapping
The current state of the art for VT ablation relies
upon creation of voltage and activation sequence
maps of endocardial and occasionally epicardial
surfaces as surrogates of the VT substrate and
mechanism of action. The surface voltage map
provides a representation of scar as low-voltage and
healthy tissue as high-voltage (1.5 mV) regions.
Similarly, an activation sequence map provides a
surface view of a re-entrant circuit or the site of
early activation in a focal arrhythmia. If electro-
physiology maneuvers confirm the necessity of a
candidate surface site for VT maintenance, the site
is ablated (most commonly) with radiofrequency
energy. Thus, current techniques for VT mapping
and ablation are built on the necessary assumption
that a scar and/or activation map of the myocardial
surface (Fig. 1A) portrays representative informa-
tion regarding the entire myocardial thickness.
However, myocardial scar is often complex, with
shapes that vary with the depth of the myocardium
(Fig. 1B). In their seminal work on identification of
critical sites during VT ablation, Stevenson et al. (3)
warned that “a variety of reentrant circuit configu-
rations are possible involving subepicardial, suben-
docardial, and intramural reentry pathways.” The
implications of this important point are illustrated
in Figure 1C, where endocardial surface mapping
may provide a substantially different voltage and/or
activation sequence map than mapping from the
epicardial surface. The figure also illustrates that
mapping from either surface may fail to identify
areas of mid-wall fibrosis (scar island 2). Midwall
scar can be seen in up to 30% of patients with
nonischemic cardiomyopathy (4,5). Although the
report by Ilg et al. (2) focuses on idiopathic VT
where no underlying structural scar is expected, the
authors used late gadolinium enhancement (LGE)
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287mages to identify the underlying substrate im-
arted by prior ablations during repeat procedures.
ntegration of LGE scar maps with electroanatomic
apping data as described by the authors provides
nformation regarding the myocardial substrate
eep to our current sampling strategy and will likely
mprove outcomes.
esion Depth and Efﬁcacy of Ablation
he effectiveness of ablation at destroying the
argeted tissue is currently assessed by lack of
yocardial capture with pacing after ablation.
owever, lack of capture provides information
egarding tissue destruction at the catheter–tissue
nterface and not regarding the depth of myocar-
ium ablated. Figure 2A illustrates the case of a
e-entrant circuit where application of a lesion to
he critical isthmus (red dot, Fig. 2B) may be
xpected to render the arrhythmia noninducible.
owever, if the catheter–tissue interface is ablated,
acing may not capture local myocardium despite
he presence of surviving tissue in the critical zone
or re-entry but deep to the endocardial surface
Fig. 2C). Thus, the difference between a poor
onstruct of the arrhythmia mechanism versus an
neffective lesion is not readily discernible. The
apacity to image lesions may provide feedback
Figure 1. Two-Dimensional Representation of 3-Dimensional
Structures and Circuits
(A) Two-dimensional re-entrant circuit construct based upon
surface mapping. Arrows indicate possible excitation wave
fronts. (B) Representation of the scar islands in (A) if we were
able to map the depth of myocardium. Scar morphologies illus-
trated by islands 1 and 3 may be seen in ischemic cardiomyopa-
thy. In contrast, scar island 2 represents mid-wall ﬁbrosis. (C)
Surface mapping from the endocardium may provide substan-
tially different information regarding voltage characteristics and
the electrical activation sequence than surface mapping from
the epicardium. Panel A is adapted from Stevenson et al. (3).egarding lesion adequacy and reasons for ablation Hailure. Ilg et al. (2) have expanded the knowledge
egarding lesion visualization using CMR (6,7), by
eporting LGE results before and after ventricular
blation. Interestingly, in nearly a third of patients,
o lesions were identified. It is likely that with
mprovements in high-resolution LGE imaging,
esions applied to thin areas of the myocardium
uch as the right ventricular outflow tract will be
esolved. Additionally, the optimal post-contrast
elay, and the optimal inversion time for scar
esolution, are not uniform across the myocardium
nd will likely need to be adjusted for each region of
nterest (8). Nevertheless, the findings by Ilg et al.
2) suggest that lesion location, size, and depth can
e discerned after catheter ablation in the majority
f patients with idiopathic ventricular arrhythmia.
he results, however, may not be generalizable to
atients with structural VT, where resolution of the
esion from pre-existing scar that borders the lesion
ay prove challenging. Future studies to expand the
ndings of Ilg et al. (2) to patients with structural
T are warranted.
It is generally accepted that longer ablation du-
ation, larger electrode catheters, and cooled radio-
requency catheters produce larger lesions (9). Ilg et
l. (2) confirm a correlation between lesion size and
uration of ablation. The authors also report larger
esion volumes when a combination of 4-mm-tip
nd 8-mm-tip catheters was used than when an
pen cooled radiofrequency catheter was used.
Figure 2. Failure of the Construct or of Lesion Depth?
(A) Example of a re-entrant circuit. Arrows indicate a possible
excitation wave front through the circuit. (B) A possible critical
isthmus (red dot) where ablation may be expected to render
the arrhythmia noninducible. (C) A lesion applied from the
endocardial surface may fail to terminate ventricular tachycardia,
not because of an incorrect construct of the arrhythmia, but
because of ineffective depth achieved by ablation.owever, they noted no significant differences be-
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288ween lesions created using open cooled versus
oncooled radiofrequency catheters. Factors that
ay contribute to discrepancies in lesion size versus
atheter design correlations across studies may in-
lude variations in power and temperature settings,
lood flow, electrode–tissue orientation and con-
act, and sample sizes. To control for these param-
ters, most previous studies have assessed lesion size
ersus catheter design correlations using in vitro mod-
ls. In vitro models, however, may not accurately
eproduce the local perfusion and blood flow patterns
n the intact human heart. Additional CMR studies of
n vivo lesion formation will likely improve our un-
erstanding of the capabilities, advantages, and disad-
antages of unique catheter designs.
uture Development
lg et al. (2) report the use of CMR for evaluationet al. Magnetic resonance assessment Detection of pulmorrhythmia. This methodology can provide infor-
ation regarding a dimension of ventricular muscle
reviously untapped due to limitations of surface
apping. Ultimately, real-time CMR guidance of
T ablation may provide the electrophysiologist
ith live information regarding the underlying scar
ubstrate for VT and allow precise titration of
esions. Improved techniques to integrate CMR for
dentification of scar arrhythmia substrates and
onitoring of lesion formation will likely improve
he safety and efficacy of VT ablation.
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